Swiss National Bank’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-67,600
| Closed | -$330K | – | 2755 |
|
|
2022
Q1 | $330K | Buy |
67,600
+5,100
| +8% | +$24.9K | ﹤0.01% | 2654 |
|
|
2021
Q4 | $707K | Hold |
62,500
| – | – | ﹤0.01% | 2580 |
|
|
2021
Q3 | $911K | Buy |
62,500
+2,100
| +3% | +$30.6K | ﹤0.01% | 2466 |
|
|
2021
Q2 | $704K | Buy |
60,400
+5,000
| +9% | +$58.3K | ﹤0.01% | 2580 |
|
|
2021
Q1 | $676K | Buy |
55,400
+2,000
| +4% | +$24.4K | ﹤0.01% | 2426 |
|
|
2020
Q4 | $668K | Buy |
53,400
+1,800
| +3% | +$22.5K | ﹤0.01% | 2420 |
|
|
2020
Q3 | $777K | Buy |
51,600
+4,200
| +9% | +$63.2K | ﹤0.01% | 2226 |
|
|
2020
Q2 | $1.16M | Buy |
+47,400
| New | +$1.16M | ﹤0.01% | 2024 |
|